Addiction Neuroscience (Sep 2023)

Working Title: Smoking cessation, harm reduction, and biomarkers protocols in the PhenX Toolkit: Tools for standardized data collection

  • Laura Jean Bierut,
  • Tabitha P. Hendershot,
  • Neal L. Benowitz,
  • K. Michael Cummings,
  • Robin J. Mermelstein,
  • Megan E. Piper,
  • Scott I. Vrieze,
  • Theodore L. Wagener,
  • Mark D. Nelms,
  • Cataia Ives,
  • Deborah Maiese,
  • Carol M. Hamilton,
  • Gary E. Swan

Journal volume & issue
Vol. 7
p. 100081

Abstract

Read online

The use of standard protocols in studies supports consistent data collection, improves data quality, and facilitates cross-study analyses. Funded by the National Institutes of Health, the PhenX (consensus measures for Phenotypes and eXposures) Toolkit is a catalog of recommended measurement protocols that address a wide range of research topics and are suitable for inclusion in a variety of study designs. In 2020, a PhenX Working Group of smoking cessation experts followed a well-established consensus process to identify and recommend measurement protocols suitable for inclusion in smoking cessation and smoking harm reduction studies. The broader scientific community was invited to review and provide feedback on the preliminary recommendation of the Working Group. Fourteen selected protocols for measuring smoking cessation, harm reduction, and biomarkers research associated with smoking cessation were released in the PhenX Toolkit (https://www.phenxtoolkit.org) in February 2021. These protocols complement existing PhenX Toolkit content related to tobacco regulatory research, substance use and addiction research, and other measures of smoking-related health outcomes. Adopting well-established protocols enables consistent data collection and facilitates comparing and combining data across studies, potentially increasing the scientific impact of individual studies.

Keywords